Not_yet_recruitingNANCT07631026

Wearable Device Tracked Recovery From Autologous Breast Reconstructive Surgery

Sponsor: M.D. Anderson Cancer Center

Trial Details

ConditionBreast Cancer
InterventionQuestionnaires; Questionnaires; Questionnaires
PhaseNA
StatusNot_yet_recruiting
Participants50
Est. Completion31 Dec 2027
Last Updated27 July 2026

Primary Outcome

Safety and Adverse Events (AEs)

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: * Age ≥ 18 years. * Scheduled for delayed\[SH6.1\]\[PH6.2\] unilateral or bilateral DIEP flap breast reconstruction. * Able and willing to provide informed consent. * Possession of a compatible smartphone or tablet capable of syncing with the Fitbit Inspire 3 app. * Willingness to wear the activity tracker continuously for three weeks preoperatively and three months postoperatively. Exclusion Criteria: * Inability or unwillingness to wear a wrist-worn activity tracker. * Significant dermatologic conditions, wound, or allergy preventing safe use of a wrist-worn device. * Planned additional concurrent surgical procedure (non-reconstructive) expected to significantly alter activity level or recovery trajectory (i.e. BSO, CPM). * Participation in another interventional clinical trial that may confound activity or recovery data. * Inability to provide informed consent or complete required questionnaires.

Trial Sites

Countries

United States
View Registry Entry

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service